Metabolomic Diagnostics secures €1.6M investment

DC 16/06/2016 - REPRO FREE FREE PIC Irish biotech company, Metabolomic Diagnostics, has secured a further €2 million in venture funding to help complete PrePsia, its pre-eclampsia screening test for first time pregnant mothers.  Pictured here with 4 day old baby Molly, are Frank Walsh, Partner, Enterprise Equity, Bill Liao, European Investment Partner, SOSventures, Charles Garvey, CEO, Metabolomic Diagnostics, and Prof. Louise Kenny, Consultant Obstetrician at CUMH & Director of the INFANT Centre. Pic: Diane Cusack

Frank Walsh, Partner, Enterprise Equity, Bill Liao, European Investment Partner, SOSventures, Charles Garvey, CEO, Metabolomic Diagnostics, and Prof. Louise Kenny, Consultant Obstetrician at CUMH & Director of the INFANT Centre.

Irish biotech company, Metabolomic Diagnostics, has secured an additional €1.6 million from investors to help complete PrePsia™, its new screening test for pre-eclampsia in first time pregnant mothers.

Continue Reading

Future bright for Limerick region

Dr James Ring, Limerick Chamber CEO, Catherine Duffy, President, Limerick Chamber with Martin Shanahan, CEO, IDA Ireland

Dr James Ring, Limerick Chamber CEO, Catherine Duffy, President, Limerick Chamber with Martin Shanahan, CEO, IDA Ireland

The Limerick region is currently going through a renaissance when it comes to jobs and investment. That was the key message to come out of a meeting between Limerick Chamber and IDA Ireland.

Continue Reading

No more posts.